Source: Annual Congress 2007 - Invasive and noninvasive methods to assess airway inflammation



Rating:

Share or cite this content

Citations should be made in the following way:
C. Dagnell, H. Haugom-Olsen, C. Kemi, M. Skold, A. Eklund, J. Grunewald, C. Olgart Hoglund (Stockholm, Sweden). Elevated NT-3 levels in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. Eur Respir J 2007; 30: Suppl. 51, 3472

Member's Comments

No comment yet.

Related content which might interest you: CCL20 level in bronchoalveolar lavage fluid is correlated with the levels of serum indications in patients with pulmonary sarcoidosis Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 Concentration of sFas in bronchoalveolar lavage fluid of smoking patients with sarcoidosis Source: Annual Congress 2012 - Sarcoidosis Year: 2012 Soluble Fas-ligand levels in bronchoalveolar lavage fluid before and after interferon-γ-1b treatment in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 334s Year: 2005 Cytokine profiles of bronchoalveolar lavage fluid in patients with combined pulmonary fibrosis and emphysema Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry Source: Annual Congress 2005 - Progresses in granolomatous lung disease Year: 2005 Th1/Th2/Th17-related cytokines in the bronchoalveolar lavage fluid of patients with sarcoidosis in relation to smoking Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 The analysis of tryptase in serum and bronchoalveolar lavage of sarcoidosis patients Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 Induced sputum versus bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2003; 22: Suppl. 45, 227s Year: 2003 High levels of pepsin A in bronchoalveolar lavage fluid of patients with exacerbation of interstitial lung diseases and no evidence of infection Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 The coagulation and antifibrynolitic activities are increased in the bronchoalveolar lavage fluid from patients with progressing idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 575s Year: 2007 Increased Clara cell protein 16 levels in the bronchoalveolar lavage fluid of idiopathic pulmonary fibrosis patients Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 Interleurin-4 and immunoglobulin E levels in bronchoalveolar lavage fluid and blood serum in patients with bronchial asthma and lung tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 271s Year: 2001 Coagulation activity of bronchoalveolar lavage fluid and blood is dependent on pulmonary sarcoidosis stage Source: Eur Respir J 2003; 22: Suppl. 45, 84s Year: 2003 Elevated transforming growth factor (TGF)-β1 and thrombospondin (TSP)-1 levels in bronchoalveolar lavage (BAL) fluid of patients with pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 83s Year: 2003 The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Calgranuline B in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Tryptase levels in bronchoalveolar lavage fluid (BALF) may predict the recurrence and chronicity of eosinophilic pneumonia Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 Elevated TGF- b1 concentration in bronchoalveolar lavage fluid from patients with primary lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002 ECP and EPX in bronchoalveolar lavage fluid in children with cystic fibrosis and mild lung disease Source: Eur Respir J 2001; 18: Suppl. 33, 538s Year: 2001 Comparison between induced sputum and bronchoalveolar lavage fluid for diagnosis of pulmonary tuberculosis Source: Annual Congress 2010 - Scientific advances in tuberculosis Year: 2010